NIMBUS®, NimbuDerm™ and MultiStat™ Technologies Selected for Presentation at Prestigious 3rd Congress of the World Union of Wound Healing Societies in Toronto

Gainesville, Florida – May 21, 2008 – Quick-Med Technologies, Inc. announced that the company will participate in the Third Congress of the World Union of Wound Healing Societies being held in Toronto, Ontario on June 4-8, 2008.

Three poster abstracts have been accepted for presentation:

"Absorbent Microbicidal Wound Dressing Material with Protease Inhibitor Properties" – B. Liesenfeld, G. Schultz, J. Azeke, O. Moloye, W. Toreki, D. Moore, J. Olderman and R. Carr; Quick-Med Technologies, Inc. and the University of Florida at Gainesville.

"Protease Inhibitors Prevent Microvesication in Sulfur Mustard Wounds on Human Skin Explant" - B. Liesenfield, M. Mol and G. Schultz; Quick-Med Technologies, Inc., TNO Laboratories, Netherlands and the University of Florida at Gainesville.

"Persistent Skin Sanitizer with Sustained Microbicidal Properties" - W. Toreki, D. Moore, B. Liensenfield, J. Vella, G. Schultz, J. Olderman and R. Carr; Quick-Med Technologies, Inc. and the University of Florida at Gainesville.

Wound care is a major healthcare market with an estimated value of $10 billion in 2007, predicted to grow to $12.5 billion in 2012. The $4.6 billion global advanced wound care segment is the fastest growing area with double-digit growth of 10% per year. This growth is being driven by an ageing population, the rise in the incidence of diabetes worldwide and a steady advancement in technology and products that are more clinically efficient and cost-effective than their conventional counterparts..

To schedule a meeting with Quick-Med Technologies, please contact Roy D. Carr, Director of Business Development - Medical Devices at (561) 771-1306.

About Third Congress of the World Union of Wound Healing Societies

The primary goal of the World Union of Wound Healing Societies 2008 Congress, sponsored and hosted by the University of Toronto, will be to present the wound care evidence base and transfer the knowledge, skills, and attitudes for improved patient outcomes. This will be accomplished through a five-day meeting that includes a pre-conference day, three plenary sessions, and 10 concurrent streams with more than 100 educational sessions. For more information, see: www.wuwhs2008.com

About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. For more information, see:www.quickmedtech.com

Contact:

Natasha A. Sorobey -- Corporate & Investor Relations (Canada)
Phone: (888) 835-2211 Ext. 107
Email: info@quickmedtech.com

Forward-looking statements (statements which are not historical facts) in this release are
made pursuant to the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. For this purpose, any statements contained in this release that are not
statements of historical fact may be deemed to be forward-looking statements. Without
limiting the generality of the foregoing, words such as "may", "will", "to", "expect",
"plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue"
or the negative or other variations thereof or comparable terminology is intended to
identify forward-looking statements involve risks and uncertainties, including those risks
that are discussed in the Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.